-
Posted by
Two Blokes Jul 22 -
Filed in
Stock
-
8 views
UnitedHealth Group's stock has sharply declined due to an earnings miss, guidance cut, CEO exit, and rising medical costs, creating a rare value opportunity. Valuation metrics show UNH trading at deep discounts to historical and industry averages, despite strong long-term growth prospects and insider buying. UNH maintains industry-leading margins and growth, with a dominant Medicare Advantage position and vertical integration through Optum driving future earnings potential.
